Literature DB >> 152321

The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes.

R Rosa, M O Prehu, Y Beuzard, J Rosa.   

Abstract

An inherited and complete deficiency of diphosphoglycerate mutase was discovered in the erythrocytes of a 42-yr-old man of French origin whose blood hemoglobin concentration was 19.0 g/dl. Upon physical examination he was normal with the exception of a ruddy cyanosis. The morphology of his erythrocytes was also normal and there was no evidence of hemolysis. The erythrocyte 2,3-diphosphoglycerate level was below 3% of normal values and, as a consequence, the affinity of the cells for oxygen was increased. Diphosphoglycerate mutase activity was undetectable in erythrocytes as was that of diphosphoglycerate phosphatase. The activities of all the other erythrocyte enzymes that were tested were normal except for nomophosphoglycerate mutase which was diminished to 50% of the normal value. The levels of reduced glutathione, ATP, fructose 1,6-diphosphate, and of triose phosphates were elevated, whereas those of glucose 6-phosphate and fructose 6-phosphate were decreased. This report sheds new light on the role of diphosphoglycerate mutase in the metabolism of erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 152321      PMCID: PMC371847          DOI: 10.1172/JCI109218

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Familial diphosphoglyceratemutase deficiency. Influence on the oxygen affinity curves of hemoglobin.

Authors:  D Labie; J -P. Leroux; A Najman; C Reyrolle
Journal:  FEBS Lett       Date:  1970-07-15       Impact factor: 4.124

2.  Evidence for three enzymatic activities in one electrophoretic band of 3-phosphoglycerate mutase from red cells.

Authors:  R Rosa; I Audit; J Rosa
Journal:  Biochimie       Date:  1975       Impact factor: 4.079

3.  Glycerate-2,3-diphosphatase.

Authors:  S RAPOPORT; J LUEBERING
Journal:  J Biol Chem       Date:  1951-04       Impact factor: 5.157

4.  A comparison of some of the physical and chemical properties of the phosphoglycerate mutases from human erythrocytes.

Authors:  L F Hass; R H Sheibley; W K Kappel; K B Miller
Journal:  Biochem Biophys Res Commun       Date:  1976-10-04       Impact factor: 3.575

5.  2,3-diphosphoglycerate phosphatase from human erythrocytes. General properties and activation by anions.

Authors:  Z B Rose; J Liebowitz
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

6.  The biosynthesis of 2,3-diphosphoglycerate by monophosphoglycerate mutase from muscle and erythrocytes.

Authors:  M T Laforet; J B Butterfield; J B Alpers
Journal:  Arch Biochem Biophys       Date:  1974-11       Impact factor: 4.013

7.  Purification and properties of 2, 3-diphosphoglyceric acid phosphatase from human erythrocytes.

Authors:  D R Harkness; S Roth
Journal:  Biochem Biophys Res Commun       Date:  1969-03-31       Impact factor: 3.575

8.  Kinetic studies on the inhibition of glycolytic kinases of human erythrocytes by 2,3-diphosphoglyceric acid.

Authors:  J Ponce; S Roth; D R Harkness
Journal:  Biochim Biophys Acta       Date:  1971-10

Review 9.  Pyruvate kinase deficiency and related disorders of red cell glycolysis.

Authors:  A S Keitt
Journal:  Am J Med       Date:  1966-11       Impact factor: 4.965

10.  Direct determination of 2,3-diphosphoglycerate.

Authors:  Z B Rose; J Liebowitz
Journal:  Anal Biochem       Date:  1970-05       Impact factor: 3.365

View more
  19 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Functional lysine modification by an intrinsically reactive primary glycolytic metabolite.

Authors:  Raymond E Moellering; Benjamin F Cravatt
Journal:  Science       Date:  2013-08-02       Impact factor: 47.728

Review 3.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

4.  Hereditary triose phosphate isomerase deficiency: seven new homozygous cases.

Authors:  R Rosa; M O Prehu; M C Calvin; J Badoual; D Alix; R Girod
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  A recombinant bisphosphoglycerate mutase variant with acid phosphatase homology degrades 2,3-diphosphoglycerate.

Authors:  M C Garel; N Arous; M C Calvin; C T Craescu; J Rosa; R Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  Effect of vibration on red cell metabolism.

Authors:  R Andrzejak; R Smolik
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

Review 7.  Diagnosis of red blood cell enzymopathies in infants, children and adolescents.

Authors:  S P Samuel; T D Miale
Journal:  Indian J Pediatr       Date:  1987 May-Jun       Impact factor: 1.967

8.  An enzyme-linked immunosorbent assay and reference ranges for bisphosphoglycerate mutase in human erythrocytes.

Authors:  T Takubo; I Tsuda; N Tatsumi; K Kasuya; Y Taniguchi; T Fujita; K Uchida; Y Matsuo; T Hayashi
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

9.  Diagnosis and management of congenital and idiopathic erythrocytosis.

Authors:  Mary Frances McMullin
Journal:  Ther Adv Hematol       Date:  2012-12

10.  Dephosphorylation of 2,3-bisphosphoglycerate by MIPP expands the regulatory capacity of the Rapoport-Luebering glycolytic shunt.

Authors:  Jaiesoon Cho; Jason S King; Xun Qian; Adrian J Harwood; Stephen B Shears
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.